StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the stock.
China Pharma Stock Performance
NYSE:CPHI opened at $0.25 on Thursday. China Pharma has a fifty-two week low of $0.24 and a fifty-two week high of $1.77. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.89 and a quick ratio of 0.25. The business has a 50 day moving average price of $0.27 and a 200-day moving average price of $0.35.
China Pharma (NYSE:CPHI – Get Free Report) last released its quarterly earnings data on Wednesday, May 15th. The company reported ($0.07) earnings per share for the quarter. The company had revenue of $1.37 million for the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- The How And Why of Investing in Oil Stocks
- Is Crypto Cool Again? What Stocks You Should Be Watching
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Why Call Options Volume for These 2 Stocks Spiked Together
- ETF Screener: Uses and Step-by-Step Guide
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
